Sigint Bio
Stealth ModeDeveloping novel therapeutics for cancer by targeting the tumor microenvironment.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does Sigint Bio do?
Sigint Bio is a biotechnology company focused on developing innovative cancer therapies. They aim to address the challenges posed by the tumor microenvironment, a complex ecosystem that can shield tumors from treatment and promote resistance. Their approach involves identifying and targeting key pathways within this microenvironment to enhance the efficacy of existing and novel cancer treatments.
How much funding has Sigint Bio raised?
Sigint Bio has raised a total of $100M in funding. The most recent round on record is Series B.
Where is Sigint Bio headquartered?
Sigint Bio is headquartered in פתח תקווה, Israel.
When was Sigint Bio founded?
Sigint Bio was founded in 2026.
What industry does Sigint Bio operate in?
Sigint Bio operates in Biotech, Drug Discovery, Oncology, Tumor Microenvironment, Therapeutics, Clinical Trials.